Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma

Liping Liu,Ningning Zhao,WenJun Xu,Zhixin Sheng,Lida Wang

Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma

2016

Liping Liu
Ningning Zhao
WenJun Xu
Zhixin Sheng
Lida Wang

Purpose The purpose of this study was to better understand the efficacy and safety of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma(R/RMM).

Keywords:

Cancer research
Elotuzumab
Immunology
Panobinostat
Hematology
Carfilzomib
Biology
Multiple myeloma
Internal medicine
Refractory
in patient
Oncology
Salvage therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations